RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT)

Historical Holders from Q4 2019 to Q3 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
RAPT on Nasdaq
Shares outstanding
16,463,909
Price per share
$25.79
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,972,512
Total reported value
$76,661,084
% of total 13F portfolios
0%
Share change
+1,631,462
Value change
+$42,075,407
Number of holders
3
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Medicxi IV LP 17% $19,446,240 22,352,000 Medicxi IV GP Limited 27 Dec 2024
Deep Track Capital, LP 9.9% $12,280,920 14,116,000 Deep Track Capital, LP 23 Dec 2024
Redmile Group, LLC 9.9% $12,121,231 13,932,449 Redmile Group, LLC 31 Dec 2024
TCG Crossover GP II, LLC 10% $11,478,006 13,193,110 TCG Crossover GP II, LLC 27 Dec 2024
Foresite Capital Fund VI LP 9.3% $10,875,000 12,500,000 Foresite Capital Fund VI, L.P. 23 Dec 2024
RTW INVESTMENTS, LP 8.9% $10,234,680 11,764,000 RTW Investments, LP 31 Mar 2025
VANGUARD GROUP INC 6.3% +202% $7,202,554 +$4,651,367 8,278,798 +182% The Vanguard Group 31 Mar 2025
PERCEPTIVE ADVISORS LLC 4.5% $5,115,600 5,880,000 Perceptive Advisors LLC 31 Dec 2024
BlackRock, Inc. 1.7% $2,006,761 2,306,622 BlackRock, Inc. 31 Mar 2025
COLUMN GROUP II, LP 4.9% $1,395,126 1,603,593 Peter Svennilson 23 Dec 2024
ORBIMED ADVISORS LLC 6.6% -33% $28,023,878 -$310,734,477 1,086,618 -92% ORBIMED ADVISORS LLC 30 Sep 2025
FMR LLC 0.4% $418,041 480,507 FMR LLC 31 Jan 2025
As of 30 Sep 2025, RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) has 3 institutional shareholders filing 13F forms. They hold 2,972,512 shares. of 16,463,909 outstanding shares (18%) .

Top 3 institutional shareholders own 18% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Medicxi Ventures Management (Jersey) Ltd 17% 2,794,000 9.7% $72,057,260
Column Group LLC 1% 166,075 -88% 5.3% $4,283,074
AJU IB Investment Co., Ltd. 0.08% 12,437 0% 0.28% $320,750

Institutional Holders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 2,972,512 $76,661,084 +$42,075,407 $25.79 3
2025 Q2 1,341,050 $10,728,400 -$158,903,455 $8.00 2
2025 Q1 131,135,934 $159,984,594 +$4,424,695 $1.22 89
2024 Q4 126,888,838 $199,480,129 +$130,912,564 $1.58 89
2024 Q3 29,799,656 $59,894,847 -$5,399,235 $2.01 92
2024 Q2 31,808,667 $97,015,342 -$20,514,565 $3.05 100
2024 Q1 31,957,297 $286,976,309 -$135,887,644 $8.98 120
2023 Q4 34,982,104 $869,312,485 +$6,735,986 $24.85 108
2023 Q3 34,763,427 $577,769,050 +$11,319,522 $16.62 96
2023 Q2 34,050,266 $636,743,238 +$14,411,769 $18.70 97
2023 Q1 33,297,098 $610,504,496 +$19,762,513 $18.35 104
2022 Q4 32,051,948 $634,583,743 +$67,138,151 $19.80 92
2022 Q3 29,977,976 $705,685,698 -$6,718,488 $24.06 96
2022 Q2 29,739,176 $542,744,027 +$30,137,398 $18.25 83
2022 Q1 28,022,792 $616,047,645 -$11,376,493 $21.99 82
2021 Q4 26,299,986 $965,984,248 +$58,612,650 $36.73 96
2021 Q3 24,839,747 $731,027,543 +$65,328,555 $31.05 104
2021 Q2 26,596,757 $845,609,249 +$179,542,242 $31.79 107
2021 Q1 20,992,943 $466,036,000 +$14,749,147 $22.20 77
2020 Q4 20,445,788 $403,803,000 +$1,193,976 $19.75 80
2020 Q3 16,829,467 $541,869,734 +$65,277,706 $32.20 66
2020 Q2 14,821,430 $430,109,022 +$93,891,523 $29.02 52
2020 Q1 11,682,494 $247,909,000 +$53,863,363 $21.27 37
2019 Q4 2,361,079 $64,437,000 +$64,437,000 $27.61 25